Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Agenus reported $190.9M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
Amgen AMGN:US USD 14.22B 1.47B
AstraZeneca AZN:LN USD 24.86B 1.43B
Celldex Therapeutics CLDX:US USD 15.22M 3.39M
CSL CSL:AU USD 4.33B 2.78B
Dynavax Technologies DVAX:US USD 91.52M 58.56M
Eli Lilly LLY:US USD 16.01B 1.13B
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Glaxosmithkline GSK:US GBP 20.7B 2.11B
Immunogen IMGN:US USD 101.63M 20.23M
Incyte Corp INCY:US USD 1.01B 150.97M
Intrexon XON:US USD 46.73M 31.91M
J&J JNJ:US USD 60.37B 4.57B
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
MacroGenics MGNX:US USD 45.61M 3M
Merck MRK:GR EUR 9.56B 43M
Northwest Biotherapeutics NWBO:US USD 44.71M 81.3M
Novartis NOVN:VX USD 30.55B 1.89B
Novavax NVAX:US USD 1.92B 541.09M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Rigel Pharmaceuticals RIGL:US USD 45.52M 19.69M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Veracyte VCYT:US USD 55.99M 6.62M